Related Experiment Video
Updated: Nov 4, 2025
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
782
Update on pediatric metabolic and bariatric surgery
Dani O Gonzalez1, Marc P Michalsky1
1Department of Pediatric Surgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Pediatric Obesity
|May 27, 2021
Summary
Metabolic and bariatric surgery is an effective treatment for severe childhood obesity, offering long-term health benefits. Earlier intervention and improved access to care are crucial for pediatric patients.
Area of Science:
- Pediatric Endocrinology
- Bariatric Medicine
- Public Health
Background:
- Childhood obesity prevalence has surged, posing significant health risks.
- Obesity in youth leads to cardiometabolic issues and reduced quality of life.
Purpose of the Study:
- To review the role of metabolic and bariatric surgery in treating severe pediatric obesity.
- To highlight the benefits of early intervention and multidisciplinary care models.
Main Methods:
- Literature review on metabolic and bariatric surgery outcomes in pediatric patients.
- Analysis of current challenges and future directions in pediatric obesity management.
Main Results:
- Metabolic and bariatric surgery demonstrates positive long-term health effects in children.
- Earlier surgical intervention is associated with greater long-term health advantages.
Conclusions:
- Metabolic and bariatric surgery is a viable and effective treatment for severe pediatric obesity.
- Addressing access to care challenges is essential to ensure timely referrals for eligible youth.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
49
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
49
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
62
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
62
01:26Kidney Transplant II: Surgical Procedure
109
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
109
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
397
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
397
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
41
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
41